Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 51 | 51 | 0 |
| Shares | 26.6M | 25.8M | −788.2K (−3.0%) |
| Value | $12.6M | $9.31M | −$3.30M (−26.2%) |
New holders (5)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 90,298 | $33.0K | 0.00% |
| UBS Group AG | 14,307 | $5.15K | 0.00% |
| Baader Bank INC | 12,544 | $3.50K | 0.00% |
| HRT Financial LP | 10,253 | $3.00K | 0.00% |
| Global Wealth Management Investment Advisory, Inc. | 650 | $234 | 0.00% |
Sold out (5)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Jane Street Group, LLC | 57,963 | $27.2K |
| Susquehanna International Group, LLP | 14,734 | $6.92K |
| Financial Advocates Investment Management | 10,000 | $4.70K |
| BNP Paribas Arbitrage, SA | 79 | $37 |
| Bank of America Corp | 6 | $3 |